Articles On Neuren Pharmaceuticals (ASX:NEU)

The Mesoblast Ltd (ASX: MSB) share price is in focus today after the company announced a 69% quarter-on-quarter increase in net revenues from its lead product Ryoncil®, reaching US$20.6 million for the September quarter. Cash on hand also...

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price is in focus today after the company revealed that the US FDA has granted Fast Track designation for its NNZ-2591 treatment in Phelan-McDermid syndrome (PMS). This marks a significant mil...

Highlights Gold and critical minerals lead midday momentum across large, mid, and small names Defensive infrastructure and logistics display steady relative strength Technology, healthcare, and consumer brands face pressure...

PainChek can now tackle the US$100 million US aged-care market – while other geographies beckon Trivarx shares leap 9% on depression detection trial results Dimerix gets more assurances on using surrogate endpoints in its pivotal kidney t...

US FDA grants Rare Paediatric Disease Designation for Neurotech’s NTI164 for treatment of Rett syndrome Designation helps facilitate innovative treatments for rare paediatric diseases with enhanced regulatory support and potential priorit...

ALS Ltd (ASX: ALQ) is an ASX industrials stock that has already flown 40% higher in 2025.  In fact, it has repeatedly hit all-time highs this year.  It recently gained attention from a leading fund manager in the last couple of months...

S&P/ASX 200 Index (ASX: XJO) gold stock Vault Minerals Ltd (ASX: VAU) has been making some very happy investors in recent months. Though not so much today. In morning trade on Friday, Vault shares are down 1.2%, trading for 68 cents ap...

Zip Co Ltd (ASX: ZIP) shares enjoyed another month of outperformance in September. Shares in the S&P/ASX 200 Index (ASX: XJO) buy now, pay later (BNPL) stock closed out August trading for $4.26. When the closing bell rang on 30 Septemb...

Highlights Major ASX stock market movers hit fresh yearly highs and lows Resource-linked ASX mining stocks lead sector momentum Technology and industrial names mark significant performance shifts Several ASX-listed com...

ASX crawls up just 0.17pc with 7 sectors lower Healthcare sharply lower as Trump threatens tariffs on pharmaceuticals Strength in resources and banks outweighs greater market losses   Markets take stock as tariffs fire back up After a pol...

It has been a tough finish to the week for the healthcare sector. In afternoon trade, the S&P/ASX 200 Health Care index is down 1.4%. This compares unfavourably to a small gain by the broader ASX 200 index. Here's the current state of p...

The S&P/ASX 200 Index (ASX: XJO) is not exactly known for its technology investments.  However, one standout ASX-listed technology investment has increased more than 10 times in less than five years.  That stock is Life 360 Inc (...

Highlights Key ASX-listed companies marked fresh yearly highs and lows across diverse sectors. Gold miners, REITs, and financial firms dominated the high ranks. Healthcare and discretionary sectors showed weakness with multi...

Vault Minerals Limited (ASX: VAU)'s gold production will drop this financial year, but the company's shares are up more than 6% on Monday on a stronger outlook for the medium term. The multi-asset gold producer told the ASX in an announ...

The S&P/ASX 200 Index (ASX: XJO) is having a good start to the week. At the time of writing, the benchmark index is up 0.2% to 8,791.6 points. Four ASX shares that have failed to follow the market higher today are listed below. Here's...

Regis Healthcare Ltd (ASX: REG) shares are having a terrible start to the week. After hitting a record high last week, the ASX 300 share is now down a whopping 26% to $6.79. Why is this ASX 300 share crashing? Investors have been hitting th...

While the S&P 500 Index (SP: .INX) is heavily concentrated in the technology sector, the S&P/ASX 200 Index (ASX: XJO) is dominated by banking stocks and resources stocks.  In fact, around 40% of the S&P 500 Index is concentr...

It was an upbeat end to the trading week this Friday, with the S&P/ASX 200 Index (ASX: XJO) bouncing back to close 0.32% higher. After a few days of negative sentiment, investors evidently decided to...

Focus Minerals Limited (ASX: FML) says it has no idea why its shares are up more than 20% today on heavy trade volume. The company was issued a speeding ticket by the ASX and asked whether there was any information not yet disclosed to t...

S&P/ASX 200 Index (ASX: XJO) shares are rising strongly on Friday, up 0.64% to 8,801 points at the time of writing. This follows an impressive night on Wall Street with all three major United States indexes closing at record highs....

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...

A recent contract win with Malaysian oil and gas giant Petronas could spell good news for listed software provider Dug Technology Ltd (ASX: DUG). Dug earlier this month said it had signed a multi-year software-as-a-service and computing...

The S&P/ASX 200 Index (ASX: XJO) recorded another hefty loss this Thursday, with investors piling on the negativity after the dip we saw yesterday. The ASX 200 ended up dropping by 0.83% this Thursda...

Highlights Multiple ASX-listed companies witnessed significant insider transactions across diverse sectors. Directors engaged in both acquisitions and disposals, reflecting varied strategic approaches. Trading activity spann...

Highlights Healthcare Sector Faces Challenges: Companies like (ASX:CSL) are experiencing significant declines. Gold Stocks Show Resilience: (ASX:RSG), (ASX:EVN), and (ASX:RRL) demonstrate notable gains. Short Selling Activities o...

Highlights Artrya (ASX:AYA) expands with major funding for heart disease detection devices Telix Pharmaceuticals (ASX:TLX) advances brain cancer imaging with FDA alignment Argenica Therapeutics (ASX:AGN) gains traction with...

Highlights Short-selling trends mapped to miners, banks, retail, healthcare, tech, and real estate Brief, entity-rich snapshots for each company referenced with one clean ticker mention Neutral tone focused on activity, sect...

Highlights Multiple ASX-listed companies delivered corporate updates driving attention. Index reshuffles in ASX 200 and All Ordinaries reflected changing market trends. Global influences in energy, retail, and technology shaped invest...

It was back to the races for the S&P/ASX 200 Index (ASX: XJO) this Thursday, as investors shook off the pessimism that had defined the trading week thus far to push the markets back up. By the time t...

Investors endured another rough day of trading on the ASX boards this Tuesday, with the S&P/ASX 200 Index (ASX: XJO) recording its second fall for the week. By the time trading wrapped up this sessi...

Perversely, Polynovo stands to benefit from a US reimbursement cut for outpatients ASX biotechs had a poor August, but they will Spring into action Race Oncology opens Hong Kong site in “cautious” trial rollout   PolyNovo (ASX:PNV) shares...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

Neuren Pharmaceuticals Ltd (ASX: NEU) shares have been on fire in recent months. So much so, the ASX 200 healthcare stock has risen over 100% since hitting a 52-week low in April. The good news for investors is that it isn't too late to inv...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke...

Highlights Several ASX-listed stocks gained strong attention mid-week Mining, healthcare, and energy sectors showed resilience Top movers included gaming, retail, and resources companies The mid-week trading session brought encour...

It was a decent mid-week session for ASX shares and the S&P/ASX 200 Index (ASX: XJO) this Wednesday. After remaining in positive territory for most of the trading day, the ASX 200 ended up recording...

The S&P/ASX 200 Index (ASX: XJO), at risk of sounding like a broken record, hit a new record high once more this Monday, in what was a very encouraging start to the trading week for investors.  By...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

Morgans’ Scott Power describes mood at Bioshares Biotech Summit as “markedly more upbeat than prior years” with signs of a rotation back to ASX healthcare sector Power highlights nine ASX healthcare companies from summit with clear near-te...

Highlights ASX eases amid US Federal Reserve developments Gold stocks gain traction as gold prices rise Select large-cap companies show strong momentum The Australian share market traded with a softer tone during midday Friday, wi...

The ASX200 has been trading in the red leading into the close. Industrials, Health Care, and Energy were the poorest performing sectors in afternoon trade. On the green side of things, Real Estate, Discretionary, and Staples all bucke...

The S&P/ASX 200 Index (ASX: XJO) appears to have run out of gas on Thursday after its strong run. In afternoon trade, the benchmark index is down 0.2% to 8,824.6 points. Four ASX shares that are not letting that hold them back are liste...

Neuren’s US partner Acadia reports a 14% sales boost Look out for a slew of advanced clinical trial results in early 2026 IDT Australia shares plunge up to 39% after CEO departs “with immediate effect”   Despite firming US sales of its Re...

Dual-listed across the Nasdaq composite and the ASX, Neuren Pharma (ASX:NEU) has jumped +7% down under in the morning Thursday session as sales of its flagship drug DAYBUE jump +14% on Q2 2024. Listen to the HotCopper podcast for in-dept...

  Highlights Healthcare sector recovers strongly after extended underperformance across the year ASX-listed biotech and diagnostic firms report notable progress and investor interest Global partnerships and advanced tech de...

Highlights Mixed start for Australian equities with notable moves in resources and retail. Small caps continue to show early market activity. Company updates influence investor sentiment. The ASX opened the week with a blend of st...

Rett syndrome is rare but relentless Neuren struck biotech gold with Daybue Neurotech brings cannabis to the fight   Rett syndrome is the kind of diagnosis that hits hard and lingers long. It affects around one in 10,000 girls, and typica...

The S&P/ASX 200 Index (ASX: XJO) pulled back from the new all-time high we saw yesterday this session, recording a slight fall for this Thursday's trading. By the time trading closed, the ASX 200 ha...

Highlights: ASX 200 trims early losses as sectors rebound Viva Energy under pressure after first-half update Lithium and uranium stocks show mixed reactions The ASX 200 began Tuesday’s session in the red, touching earl...

Highlights Fortescue delivers strong Q4 shipment results Healthcare stocks shine despite market weakness Bapcor tumbles after weak trading update The ASX 200 ended the session in negative territory, weighed down by wid...